Venus Remedies share news, announcements and annual reports
NSE: VENUSREMBSE: 526953Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,330.20.
29 Oct: open ₹1,315.10, high ₹1,329.00, low ₹1,270.30
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,723 Cr1,337th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 14.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.78%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 66,538
Venus Remedies has 697 announcements on record, routine notices left out; 4 in the 30 days to 30 Oct 2026, the latest on 26 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Venus Remedies quarterly results
The board met on 26 Oct 2026 to consider financial results
Notice filed 14 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Venus Remedies annual reports, presentations and earnings calls
The company's own documents, latest first.Venus Remedies financials, year by year
Annual reports16
- Annual report, year to Mar 202624 Jul 2026
- Annual report, year to Mar 202524 Jul 2025
- Annual report, year to Mar 202421 Aug 2024
- Annual report, year to Mar 202322 Jul 2023, a zip file
- Annual report, year to Mar 202229 Jul 2022, a zip file
11 earlier reports
- Annual report, year to Mar 202117 Aug 2021, a zip file
- Annual report, year to Mar 20209 Nov 2020, a zip file
- Annual report, year to Mar 20194 Sep 2019, a zip file
- Annual report, year to Mar 201824 Sep 2018, a zip file
- Annual report, year to Mar 201729 Sep 2017, a zip file
- Annual report, year to Mar 201629 Sep 2016, a zip file
- Annual report, year to Mar 20153 Aug 2015, a zip file
- Annual report, year to Mar 20131 Oct 2013, a zip file
- Annual report, year to Mar 201217 Sep 2012, a zip file
- Annual report, year to Mar 201123 Sep 2011, a zip file
- Annual report, year to Mar 20101 Jul 2011, a zip file
Venus Remedies share news and announcements
Newest first. Page 1 of 14.
Oct 2026
26 Oct · Results
14 Oct · Board meeting
Sep 2026
Aug 2026
21 Aug · Amendment to AOA/MOA
20 Aug · Meeting
Jul 2026
18 Jul · Updates
7 Jul · Updates
Jun 2026
16 Jun · Updates
May 2026
26 May · Board meeting
26 May · Results
Apr 2026
Mar 2026
10 Mar · Updates
Jan 2026
29 Jan · Results
19 Jan · Board meeting
Not held on this date
12 Jan · Legal
Exchange has sought clarification from Venus Remedies Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.8 Jan · Updates
Dec 2025
Nov 2025
20 Nov · Legal
The exchange asked on 19 Nov 2025
10 Nov · Results
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Oct 2026Resultsdown 4.99%−5.6 pts vs Nifty 500market median −0.7% · volume 2.8× usual · The announcement
- 21 Jul 2026Resultsup 4.82%+4.8 pts vs Nifty 500market median −0.7% · five sessions −7.2% (−6.4 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 27 May 2026Resultsup 5.00%+4.7 pts vs Nifty 500market median −0.7% · five sessions +27.6% (+29.6 pts vs Nifty 500) · volume 0.7× usual · delivery +38.3 pts against usual · The announcement
- 30 Jan 2026Resultsup 4.74%+5.0 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−2.7 pts vs Nifty 500) · volume 3.4× usual · The announcement
- 11 Nov 2025Resultsup 13.24%+12.9 pts vs Nifty 500market median −0.7% · five sessions +18.3% (+16.8 pts vs Nifty 500) · volume 29.5× usual · delivery −21.6 pts against usual · The announcement
- 4 Aug 2025Resultsdown 2.00%−2.8 pts vs Nifty 500market median −0.7% · five sessions −9.4% (−8.4 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 27 May 2025Resultsup 10.79%+11.2 pts vs Nifty 500market median −0.7% · five sessions +26.4% (+26.7 pts vs Nifty 500) · volume 29.2× usual · delivery −23.5 pts against usual · The announcement
- 27 May 2025Board or managers changedup 10.79%+11.2 pts vs Nifty 500market median 0.0% · five sessions +26.4% (+26.7 pts vs Nifty 500) · volume 29.2× usual · delivery −23.5 pts against usual · The announcement
- 5 Feb 2025Resultsup 20.00%+19.7 pts vs Nifty 500market median −0.7% · five sessions +7.1% (+10.7 pts vs Nifty 500) · volume 7.9× usual · delivery +17.9 pts against usual · The announcement
- 30 Oct 2024Resultsdown 9.87%−9.7 pts vs Nifty 500market median −0.7% · five sessions −9.8% (−9.3 pts vs Nifty 500) · volume 6.6× usual · delivery −0.7 pts against usual · The announcement
20 earlier announcements
- 14 Aug 2024Resultsdown 12.07%−11.9 pts vs Nifty 500market median −0.7% · five sessions −12.6% (−15.5 pts vs Nifty 500) · volume 2.5× usual · delivery +5.4 pts against usual · The announcement
- 14 Aug 2024Board or managers changeddown 12.07%−11.9 pts vs Nifty 500market median 0.0% · five sessions −12.6% (−15.5 pts vs Nifty 500) · volume 2.5× usual · delivery +5.4 pts against usual · The announcement
- 15 Feb 2024Resultsdown 10.66%−11.2 pts vs Nifty 500market median −0.7% · five sessions −7.8% (−8.8 pts vs Nifty 500) · volume 4.9× usual · delivery −5.8 pts against usual · The announcement
- 10 Nov 2023Resultsup 12.17%+12.0 pts vs Nifty 500market median −0.7% · five sessions +20.0% (+17.9 pts vs Nifty 500) · volume 11.0× usual · delivery −20.3 pts against usual · The announcement
- 30 May 2023Resultsup 19.99%+19.8 pts vs Nifty 500market median −0.7% · five sessions +14.8% (+14.3 pts vs Nifty 500) · volume 4.0× usual · delivery +47.7 pts against usual · The announcement
- 10 Apr 2023Board or managers changeddown 1.20%−1.4 pts vs Nifty 500market median 0.0% · five sessions +18.7% (+17.8 pts vs Nifty 500) · volume 0.5× usual · delivery +6.4 pts against usual · The announcement
- 5 Apr 2023Board or managers changedup 3.09%+2.4 pts vs Nifty 500market median 0.0% · five sessions +14.3% (+12.0 pts vs Nifty 500) · volume 1.2× usual · delivery −1.3 pts against usual · The announcement
- 14 Nov 2022Resultsdown 1.63%−1.6 pts vs Nifty 500market median −0.7% · five sessions −4.8% (−4.2 pts vs Nifty 500) · volume 1.0× usual · delivery −2.9 pts against usual · The announcement
- 1 Aug 2022Resultsdown 0.66%−1.9 pts vs Nifty 500market median −0.7% · five sessions −10.1% (−11.7 pts vs Nifty 500) · volume 1.3× usual · delivery +7.9 pts against usual · The announcement
- 30 May 2022Resultsdown 8.54%−10.6 pts vs Nifty 500market median −0.7% · five sessions +2.3% (+0.8 pts vs Nifty 500) · volume 8.8× usual · delivery −6.4 pts against usual · The announcement
- 1 Feb 2022Resultsdown 7.35%−8.7 pts vs Nifty 500market median −0.7% · five sessions −2.3% (−1.9 pts vs Nifty 500) · volume 3.5× usual · delivery −4.3 pts against usual · The announcement
- 1 Nov 2021Resultsup 9.01%+7.6 pts vs Nifty 500market median −0.7% · five sessions +2.0% (−0.8 pts vs Nifty 500) · volume 1.2× usual · delivery −7.9 pts against usual · The announcement
- 13 Aug 2021Resultsdown 5.42%−6.1 pts vs Nifty 500market median −0.7% · five sessions −6.8% (−6.6 pts vs Nifty 500) · volume 0.4× usual · delivery +15.1 pts against usual · The announcement
- 9 Feb 2021Resultsup 3.10%+3.2 pts vs Nifty 500market median −0.7% · five sessions +5.1% (+3.6 pts vs Nifty 500) · volume 5.8× usual · delivery −15.5 pts against usual · The announcement
- 26 Feb 2020Board or managers changeddown 2.39%−1.3 pts vs Nifty 500market median 0.0% · five sessions −8.4% (−4.2 pts vs Nifty 500) · volume 0.4× usual · delivery +4.0 pts against usual · The announcement
- 14 Aug 2019Resultsup 1.07%+0.2 pts vs Nifty 500market median −0.7% · five sessions −3.4% (−3.1 pts vs Nifty 500) · volume 0.3× usual · delivery +16.1 pts against usual · The announcement
- 27 May 2019Board or managers changedup 14.16%+13.3 pts vs Nifty 500market median 0.0% · five sessions +2.4% (+1.6 pts vs Nifty 500) · volume 5.6× usual · delivery −23.2 pts against usual · The announcement
- 17 Sep 2014Credit ratingdown 0.38%−0.9 pts vs Nifty 500market median 0.0% · five sessions −5.4% (−6.2 pts vs Nifty 500) · volume 2.3× usual · The announcement
- 4 Jun 2014Dividenddown 0.35%−0.6 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−6.3 pts vs Nifty 500) · volume 1.3× usual
- 20 May 2013Dividenddown 8.01%−7.5 pts vs Nifty 500market median 0.0% · five sessions −16.3% (−12.9 pts vs Nifty 500) · volume 1.8× usual
Venus Remedies results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Total expenses | Quarter to Jun 2025 | Consolidated | 127.98 | 127.99 | 0.0% | 1 Aug 2025 | 10 Nov 2025 |
| Other income | Quarter to Jun 2025 | Consolidated | 8.69 | 3.41 | −60.8% | 1 Aug 2025 | 10 Nov 2025 |
| Profit before one-off items and tax | Quarter to Jun 2025 | Consolidated | 12.61 | 12.60 | −0.1% | 1 Aug 2025 | 10 Nov 2025 |
| Profit before tax | Quarter to Jun 2025 | Consolidated | 12.61 | 12.60 | −0.1% | 1 Aug 2025 | 10 Nov 2025 |
| Deferred tax | Quarter to Jun 2025 | Consolidated | −0.69 | −0.70 | −1.4% | 1 Aug 2025 | 10 Nov 2025 |
| Employee costs | Quarter to Jun 2025 | Consolidated | 20.30 | 20.31 | 0.0% | 1 Aug 2025 | 10 Nov 2025 |
| Other comprehensive income | Quarter to Jun 2025 | Consolidated | 2.36 | 2.35 | −0.4% | 1 Aug 2025 | 10 Nov 2025 |
| Tax | Quarter to Jun 2025 | Consolidated | 3.01 | 3.00 | −0.3% | 1 Aug 2025 | 10 Nov 2025 |
| Total comprehensive income | Quarter to Jun 2025 | Consolidated | 11.96 | 11.95 | −0.1% | 1 Aug 2025 | 10 Nov 2025 |
| Other comprehensive income that may later move into profit | Quarter to Jun 2025 | Consolidated | 3.73 | 3.72 | −0.3% | 1 Aug 2025 | 10 Nov 2025 |